90 related articles for article (PubMed ID: 15013360)
1. Young male smokers have altered platelets and endothelium that precedes atherosclerosis.
Casey RG; Joyce M; Roche-Nagle G; Cox D; Bouchier-Hayes DJ
J Surg Res; 2004 Feb; 116(2):227-33. PubMed ID: 15013360
[TBL] [Abstract][Full Text] [Related]
2. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
4. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
McNicol A; Eyer E; Jackson EC; Israels SJ
Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
[No Abstract] [Full Text] [Related]
5. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
6. Asialo von Willebrand factor binding to and aggregation of platelets: effects of inhibitors of platelet metabolism and function.
Williams SB; McKeown LP; Gralnick HR
J Lab Clin Med; 1987 May; 109(5):560-5. PubMed ID: 2437231
[TBL] [Abstract][Full Text] [Related]
7. Platelets and von Willebrand factor.
Schmugge M; Rand ML; Freedman J
Transfus Apher Sci; 2003 Jun; 28(3):269-77. PubMed ID: 12725954
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
9. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
11. Role of membrane cholesterol in platelet calcium signalling in response to VWF and collagen under stasis and flow.
van Lier M; Verhoef S; Cauwenberghs S; Heemskerk JW; Akkerman JW; Heijnen HF
Thromb Haemost; 2008 Jun; 99(6):1068-78. PubMed ID: 18521510
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation.
Ikeda Y; Handa M; Kamata T; Kawano K; Kawai Y; Watanabe K; Kawakami K; Sakai K; Fukuyama M; Itagaki I
Thromb Haemost; 1993 May; 69(5):496-502. PubMed ID: 8391728
[TBL] [Abstract][Full Text] [Related]
13. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
14. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
Kasirer-Friede A; Legrand C; Frojmovic MM
Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
16. Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy.
Aukrust P; Bjørnsen S; Lunden B; Otterdal K; Ng EC; Ameln W; Ueland T; Müller F; Solum NO; Brosstad F; Frøland SS
Thromb Haemost; 2000 Aug; 84(2):183-7. PubMed ID: 10959687
[TBL] [Abstract][Full Text] [Related]
17. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
19. Shear stress-induced binding of von Willebrand factor to platelets.
Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
[TBL] [Abstract][Full Text] [Related]
20. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
